ARTICLE | Company News
BioMotiv, Rutgers launch TamRx
February 7, 2019 11:45 PM UTC
Cancer immunotherapy company TamRx LLC (Cleveland, Ohio) launched Thursday from pharmaceutical accelerator BioMotiv LLC (Cleveland, Ohio), shooting to reach the clinic with its pan-TAM inhibitors in 2021.
The company is based on research from Rutgers University, which also has an undisclosed stake in TamRx...